A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo (original) (raw)

• Sheppard D, Rozzo C, Starr L, Quaranta V, Erle DJ, Pytela R . Complete amino acid sequence of a novel integrin beta subunit (beta 6) identified in epithelial cells using the polymerase chain reaction. J Biol Chem 1990; 265: 11502–11507.
  CAS PubMed Google Scholar
• Busk M, Pytela R, Sheppard D . Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J Biol Chem 1992; 267: 5790–5796.
  CAS PubMed Google Scholar
• Yokosaki Y, Monis H, Chen J, Sheppard D . Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains. J Biol Chem 1996; 271: 24144–24150.
  Article CAS Google Scholar
• Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319–328.
  Article CAS Google Scholar
• DiCara D, Rapisarda C, Sutcliffe JL, Violette SM, Weinreb PH, Hart IR et al. Structure-function analysis of Arg-Gly-Asp helix motifs in alpha v beta 6 integrin ligands. J Biol Chem 2007; 282: 9657–9665.
  Article CAS Google Scholar
• Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995; 108: 2241–2251.
  CAS PubMed Google Scholar
• Regezi JA, Ramos DM, Pytela R, Dekker NP, Jordan RC . Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 2002; 38: 332–336.
  Article CAS Google Scholar
• Sipos B, Hahn D, Carceller A, Piulats J, Hedderich J, Kalthoff H et al. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 2004; 45: 226–236.
  Article CAS Google Scholar
• Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005; 115: 339–347.
  Article CAS Google Scholar
• Ahmed N, Riley C, Rice GE, Quinn MA, Baker MS . Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. J Histochem Cytochem 2002; 50: 1371–1380.
  Article CAS Google Scholar
• Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y . Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer 2000; 7: 19–26.
  Article CAS Google Scholar
• Elayadi AN, Samli KN, Prudkin L, Liu YH, Bian A, Xie XJ et al. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for non-small cell lung cancer. Cancer Res 2007; 67: 5889–5895.
  Article CAS Google Scholar
• Ahmed N, Niu J, Dorahy DJ, Gu X, Andrews S, Meldrum CJ et al. Direct integrin alphavbeta6-ERK binding: implications for tumour growth. Oncogene 2002; 21: 1370–1380.
  Article CAS Google Scholar
• Morgan MR, Thomas GJ, Russell A, Hart IR, Marshall JF . The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9. J Biol Chem 2004; 279: 26533–26539.
  Article CAS Google Scholar
• Al-Hazmi N, Thomas GJ, Speight PM, Whawell SA . The 120 kDa cell-binding fragment of fibronectin up-regulates migration of alphavbeta6-expressing cells by increasing matrix metalloproteinase-2 and -9 secretion. Eur J Oral Sci 2007; 115: 454–458.
  Article CAS Google Scholar
• Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM . AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 2001; 92: 641–650.
  Article CAS Google Scholar
• Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE et al. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 2002; 23: 237–244.
  Article CAS Google Scholar
• Ramsay AG, Keppler MD, Jazayeri M, Thomas GJ, Parsons M, Violette S et al. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res 2007; 67: 5275–5284.
  Article CAS Google Scholar
• Marsh D, Dickinson S, Neill GW, Marshall JF, Hart IR, Thomas GJ . Alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res 2008; 68: 3295–3303.
  Article CAS Google Scholar
• Morgan MR, Jazayeri M, Ramsay AG, Thomas GJ, Boulanger MJ, Hart IR et al. Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. Oncogene 2011; 30: 1422–1435.
  Article CAS Google Scholar
• Azare J, Leslie K, Al-Ahmadie H, Gerald W, Weinreb PH, Violette SM et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol Cell Biol 2007; 27: 4444–4453.
  Article CAS Google Scholar
• Thomas GJ, Lewis MP, Whawell SA, Russell A, Sheppard D, Hart IR et al. Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 2001; 117: 67–73.
  Article CAS Google Scholar
• Annes JP, Chen Y, Munger JS, Rifkin DB . Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 2004; 165: 723–734.
  Article CAS Google Scholar
• Thomas GJ, Hart IR, Speight PM, Marshall JF . Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells. Br J Cancer 2002; 87: 859–867.
  Article CAS Google Scholar
• Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008; 48: 453–464.
  Article CAS Google Scholar
• Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM et al. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol 2003; 163: 1261–1273.
  Article CAS Google Scholar
• Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH et al. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 2008; 177: 56–65.
  Article CAS Google Scholar
• Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z et al. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 2008; 177: 82–90.
  Article CAS Google Scholar
• Hahm K, Lukashev ME, Luo Y, Yang WJ, Dolinski BM, Weinreb PH et al. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol 2007; 170: 110–125.
  Article CAS Google Scholar
• Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006; 116: 1606–1614.
  Article CAS Google Scholar
• Van Aarsen LA, Leone DR, Ho S, Dolinski BM, McCoon PE, LePage DJ et al. Thomas GJ, Weinreb PH, Fawell SE, Violette SM. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res 2008; 68: 561–570.
  Article Google Scholar
• Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 2002; 157: 493–507.
  Article CAS Google Scholar
• Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S et al. Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol 2005; 166: 1883–1894.
  Article CAS Google Scholar
• Aluwihare P, Mu Z, Zhao Z, Yu D, Weinreb PH, Horan GS et al. Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice. J Cell Sci 2009; 122: 227–232.
  Article CAS Google Scholar
• Cambier S, Mu DZ, O'Connell D, Boylen K, Travis W, Liu WH et al. A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth. Cancer Res 2000; 60: 7084–7093.
  CAS PubMed Google Scholar
• Su H, Kim H, Pawlikowska L, Kitamura H, Shen F, Cambier S et al. Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis. Am J Pathol 2010; 176: 1018–1027.
  Article CAS Google Scholar
• Babcook JS, Leslie KB, Olsen OA, Salmon RA, Schrader JW . A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities. Proc Natl Acad Sci USA 1996; 93: 7843–7848.
  Article CAS Google Scholar
• Ludbrook SB, Barry ST, Delves CJ, Horgan CM . The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3. Biochem J 2003; 369: 311–318.
  Article CAS Google Scholar
• Ryer EJ, Hom RP, Sakakibara K, Nakayama KI, Nakayama K, Faries PL et al. PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2006; 26: 780–786.
  Article CAS Google Scholar
• Ronnov-Jessen L, Petersen OW . Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. implications for myofibroblast generation in breast neoplasia. Lab Invest 1993; 68: 696–707.
  CAS PubMed Google Scholar
• Mateu MG, Valero ML, Andreu D, Domingo E . Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem 1996; 271: 12814–12819.
  Article CAS Google Scholar
• Kogelberg H, Tolner B, Thomas GJ, Di Cara D, Minogue S, Ramesh B et al. Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. J Mol Biol 2008; 382: 385–401.
  Article CAS Google Scholar
• Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, O'Brien DI et al. Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J Clin Invest 2010; 120: 2842–2857.
  Article CAS Google Scholar
• Fleming YM, Ferguson GJ, Spender LC, Larsson J, Karlsson S, Ozanne BW et al. TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation. Oncogene 2009; 28: 983–993.
  Article CAS Google Scholar
• Zhong Z, Carroll KD, Policarpio D, Osborn C, Gregory M, Bassi R et al. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells. Clin Cancer Res 2010; 16: 1191–1205.
  Article CAS Google Scholar
• Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene 2011; 30: 806–821.
  Article CAS Google Scholar
• Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2005; 344: 539–548.
  Article Google Scholar
• Culhane AC, Quackenbush J . Confounding effects in ‘A six-gene signature predicting breast cancer lung metastasis’. Cancer Res 2009; 69: 7480–7485.
  Article CAS Google Scholar
• DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 2011; 17: 1514–1520.
  Article CAS Google Scholar